CASR and Impaired glucose tolerance: Mice with a germline gain-of-function CaSR mutation have hypoinsulinemia, hyperglucagonemia, reduced pancreatic islet mass, and impaired glucose tolerance, which is rectifiable by calcilytic therapy.